Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Total Long-Term Assets 2010-2024 | VRTX

Vertex Pharmaceuticals total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Vertex Pharmaceuticals total long-term assets for the quarter ending September 30, 2024 were $12.436B, a 76.89% increase year-over-year.
  • Vertex Pharmaceuticals total long-term assets for 2023 were $8.586B, a 74.65% increase from 2022.
  • Vertex Pharmaceuticals total long-term assets for 2022 were $4.916B, a 26.97% increase from 2021.
  • Vertex Pharmaceuticals total long-term assets for 2021 were $3.872B, a 7.01% increase from 2020.
  
Vertex Pharmaceuticals Annual Total Long-Term Assets
(Millions of US $)
2023 $8,586
2022 $4,916
2021 $3,872
2020 $3,618
2019 $3,496
2018 $2,403
2017 $897
2016 $1,065
2015 $1,091
2014 $788
2013 $730
2012 $1,170
2011 $873
2010 $668
2009 $648
Vertex Pharmaceuticals Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $12,436
2024-06-30 $11,191
2024-03-31 $10,629
2023-12-31 $8,586
2023-09-30 $7,030
2023-06-30 $6,476
2023-03-31 $6,009
2022-12-31 $4,916
2022-09-30 $4,435
2022-06-30 $4,079
2022-03-31 $3,895
2021-12-31 $3,872
2021-09-30 $3,766
2021-06-30 $3,764
2021-03-31 $3,576
2020-12-31 $3,618
2020-09-30 $3,843
2020-06-30 $3,522
2020-03-31 $3,447
2019-12-31 $3,496
2019-09-30 $2,737
2019-06-30 $2,323
2019-03-31 $2,360
2018-12-31 $2,403
2018-09-30 $934
2018-06-30 $928
2018-03-31 $912
2017-12-31 $897
2017-09-30 $870
2017-06-30 $1,105
2017-03-31 $1,075
2016-12-31 $1,065
2016-09-30 $1,108
2016-06-30 $1,095
2016-03-31 $1,085
2015-12-31 $1,091
2015-09-30 $1,075
2015-06-30 $1,079
2015-03-31 $808
2014-12-31 $788
2014-09-30 $756
2014-06-30 $770
2014-03-31 $767
2013-12-31 $730
2013-09-30 $934
2013-06-30 $868
2013-03-31 $826
2012-12-31 $1,170
2012-09-30 $1,084
2012-06-30 $1,012
2012-03-31 $910
2011-12-31 $873
2011-09-30 $846
2011-06-30 $936
2011-03-31 $666
2010-12-31 $668
2010-09-30 $662
2010-06-30 $650
2010-03-31 $644
2009-12-31 $648
2009-09-30 $659
2009-06-30 $657
2009-03-31 $664
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $116.138B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $158.320B 15.32
Bristol Myers Squibb (BMY) United States $119.399B 50.32
Gilead Sciences (GILD) United States $112.401B 20.36
CSL (CSLLY) Australia $87.157B 0.00
Regeneron Pharmaceuticals (REGN) United States $81.098B 18.46
GSK (GSK) United Kingdom $70.384B 8.14
Argenex SE (ARGX) Netherlands $36.578B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.586B 0.00
BioNTech SE (BNTX) Germany $27.122B 0.00
Biogen (BIIB) United States $23.009B 9.88
Illumina (ILMN) United States $22.226B 81.01
BeiGene (BGNE) Cayman Islands $18.555B 0.00
Moderna (MRNA) United States $15.820B 0.00
Incyte (INCY) United States $13.817B 0.00
Genmab (GMAB) Denmark $13.666B 20.05
Insmed (INSM) United States $13.087B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.247B 28.43
Bio-Techne Corp (TECH) United States $11.326B 43.73
Vaxcyte (PCVX) United States $11.035B 0.00
Sarepta Therapeutics (SRPT) United States $10.911B 98.47
Exelixis (EXEL) United States $10.169B 23.12
Exact Sciences (EXAS) United States $9.792B 0.00
QIAGEN (QGEN) Netherlands $9.763B 20.08
Revolution Medicines (RVMD) United States $9.546B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Roivant Sciences (ROIV) United Kingdom $9.121B 0.00
Intra-Cellular Therapies (ITCI) United States $9.085B 0.00
Repligen (RGEN) United States $7.988B 104.07
Ascendis Pharma (ASND) Denmark $7.872B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.658B 7.49
Legend Biotech (LEGN) United States $7.510B 0.00
Nuvalent (NUVL) United States $6.745B 0.00
Halozyme Therapeutics (HALO) United States $6.234B 14.08
Blueprint Medicines (BPMC) United States $5.981B 0.00
Viking Therapeutics (VKTX) United States $5.860B 0.00
Cytokinetics (CYTK) United States $5.795B 0.00
Krystal Biotech (KRYS) United States $5.476B 90.67
Avidity Biosciences (RNA) United States $5.160B 0.00
ADMA Biologics Inc (ADMA) United States $5.007B 52.95
Arcellx (ACLX) United States $4.891B 0.00
Axsome Therapeutics (AXSM) United States $4.782B 0.00
Alkermes (ALKS) Ireland $4.657B 15.64
Biohaven (BHVN) United States $4.610B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.362B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.087B 0.00
Guardant Health (GH) United States $4.034B 0.00
Immunovant (IMVT) United States $3.944B 0.00
Apellis Pharmaceuticals (APLS) United States $3.828B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.684B 0.00
ImmunityBio (IBRX) United States $3.554B 0.00
Denali Therapeutics (DNLI) United States $3.553B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.471B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.137B 0.00
Merus (MRUS) Netherlands $3.114B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.102B 0.00
Vera Therapeutics (VERA) United States $3.059B 0.00
Edgewise Therapeutics (EWTX) United States $3.049B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.026B 0.00
Vericel (VCEL) United States $2.918B 985.17
Kymera Therapeutics (KYMR) United States $2.913B 0.00
SpringWorks Therapeutics (SWTX) United States $2.903B 0.00
Amicus Therapeutics (FOLD) United States $2.886B 0.00
Scholar Rock Holding (SRRK) United States $2.801B 0.00
Protagonist Therapeutics (PTGX) United States $2.769B 17.47
ACADIA Pharmaceuticals (ACAD) United States $2.724B 20.99
Janux Therapeutics (JANX) United States $2.640B 0.00
Zai Lab (ZLAB) China $2.633B 0.00
Iovance Biotherapeutics (IOVA) United States $2.606B 0.00
Twist Bioscience (TWST) United States $2.507B 0.00
Geron (GERN) United States $2.460B 0.00
Belite Bio (BLTE) United States $2.456B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.335B 0.00
IDEAYA Biosciences (IDYA) United States $2.316B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.305B 0.00
Akero Therapeutics (AKRO) United States $2.285B 0.00
Keros Therapeutics (KROS) United States $2.265B 0.00
CG Oncology (CGON) United States $2.264B 0.00
Ligand Pharmaceuticals (LGND) United States $2.252B 56.22
WAVE Life Sciences (WVE) Singapore $2.176B 0.00
Bavarian Nordic (BVNRY) Denmark $2.171B 13.30
Mirum Pharmaceuticals (MIRM) United States $2.147B 0.00
NeoGenomics (NEO) United States $2.104B 0.00
Beam Therapeutics (BEAM) United States $2.074B 0.00
Apogee Therapeutics (APGE) United States $1.957B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.943B 16.15
Disc Medicine (IRON) United States $1.933B 0.00
NovoCure (NVCR) Jersey $1.918B 0.00
Structure Therapeutics (GPCR) United States $1.913B 0.00
MannKind (MNKD) United States $1.886B 48.86
Tarsus Pharmaceuticals (TARS) United States $1.844B 0.00
Celldex Therapeutics (CLDX) United States $1.793B 0.00
Galapagos (GLPG) Belgium $1.788B 0.00
Arvinas (ARVN) United States $1.777B 0.00
Fortrea Holdings (FTRE) United States $1.770B 56.37
Certara (CERT) United States $1.668B 47.09
Dynavax Technologies (DVAX) United States $1.633B 95.54
Immunocore Holdings (IMCR) United Kingdom $1.615B 0.00
Viridian Therapeutics (VRDN) United States $1.600B 0.00
Neumora Therapeutics (NMRA) United States $1.574B 0.00
Nurix Therapeutics (NRIX) United States $1.562B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.536B 0.00
Intellia Therapeutics (NTLA) United States $1.456B 0.00
Spyre Therapeutics (SYRE) United States $1.425B 0.00
Travere Therapeutics (TVTX) United States $1.424B 0.00
Myriad Genetics (MYGN) United States $1.410B 0.00
Praxis Precision Medicines (PRAX) United States $1.389B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.384B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.373B 0.00
Novavax (NVAX) United States $1.357B 0.00
MiMedx (MDXG) United States $1.352B 35.38
Arcus Biosciences (RCUS) United States $1.345B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.286B 0.00
ANI Pharmaceuticals (ANIP) United States $1.197B 16.31
Arcutis Biotherapeutics (ARQT) United States $1.187B 0.00
Mesoblast (MESO) Australia $1.154B 0.00
Applied Therapeutics (APLT) United States $1.120B 0.00
Gyre Therapeutics (GYRE) United States $1.056B 0.00
Replimune (REPL) United States $1.021B 0.00
Cogent Biosciences (COGT) United States $1.009B 0.00
Bicara Therapeutics (BCAX) United States $0.984B 0.00
Zymeworks (ZYME) United States $0.984B 0.00
Vir Biotechnology (VIR) United States $0.981B 0.00
Septerna (SEPN) $0.977B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.977B 0.00
LENZ Therapeutics (LENZ) United States $0.976B 0.00
Upstream Bio (UPB) United States $0.975B 0.00
Nuvation Bio (NUVB) United States $0.942B 0.00
89BIO (ETNB) United States $0.930B 0.00
ArriVent BioPharma (AVBP) United States $0.925B 0.00
Immatics (IMTX) Germany $0.906B 0.00
Liquidia Technologies (LQDA) United States $0.901B 0.00
Rapport Therapeutics (RAPP) United States $0.845B 0.00
Cytek Biosciences (CTKB) United States $0.844B 0.00
Kura Oncology (KURA) United States $0.840B 0.00
Castle Biosciences (CSTL) United States $0.835B 149.05
AbCellera Biologics (ABCL) Canada $0.815B 0.00
Pacira BioSciences (PCRX) United States $0.810B 7.63
Tyra Biosciences (TYRA) United States $0.801B 0.00
Pliant Therapeutics (PLRX) United States $0.790B 0.00
Prothena (PRTA) Ireland $0.786B 0.00
Avid Bioservices (CDMO) United States $0.785B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.782B 0.00
Anavex Life Sciences (AVXL) United States $0.772B 0.00
Erasca (ERAS) United States $0.763B 0.00
CARGO Therapeutics (CRGX) United States $0.747B 0.00
Cullinan Therapeutics (CGEM) United States $0.730B 0.00
Tectonic Therapeutic (TECX) United States $0.710B 0.00
Entrada Therapeutics (TRDA) United States $0.703B 11.82
Adaptive Biotechnologies (ADPT) United States $0.692B 0.00
BioAge Labs (BIOA) United States $0.686B 0.00
AnaptysBio (ANAB) United States $0.678B 0.00
Oric Pharmaceuticals (ORIC) United States $0.677B 0.00
Arbutus Biopharma (ABUS) United States $0.665B 0.00
Dianthus Therapeutics (DNTH) United States $0.661B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.639B 0.00
Mineralys Therapeutics (MLYS) United States $0.622B 0.00
MBX Biosciences (MBX) United States $0.618B 0.00
Immunome (IMNM) United States $0.613B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.611B 0.00
Stoke Therapeutics (STOK) United States $0.605B 0.00
CorMedix Inc (CRMD) United States $0.604B 0.00
Oculis Holding AG (OCS) Switzerland $0.598B 0.00
CureVac (CVAC) Germany $0.596B 4.84
Sana Biotechnology (SANA) United States $0.583B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.577B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.575B 0.00
ChromaDex (CDXC) United States $0.568B 744.00
Humacyte (HUMA) United States $0.565B 0.00
Third Harmonic Bio (THRD) United States $0.562B 0.00
Abivax SA (ABVX) France $0.556B 0.00
GRAIL (GRAL) United States $0.555B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.554B 0.00
Annexon (ANNX) United States $0.548B 0.00
Astria Therapeutics (ATXS) United States $0.545B 0.00
PureTech Health (PRTC) United States $0.540B 0.00
IGM Biosciences (IGMS) United States $0.529B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.522B 0.00
Emergent Biosolutions (EBS) United States $0.514B 0.00
Pharming Group (PHAR) Netherlands $0.511B 0.00
Olema Pharmaceuticals (OLMA) United States $0.503B 0.00
Zenas BioPharma (ZBIO) United States $0.501B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.501B 0.00
Terns Pharmaceuticals (TERN) United States $0.492B 0.00
Celcuity (CELC) United States $0.490B 0.00
GH Research (GHRS) Ireland $0.482B 0.00
Cartesian Therapeutics (RNAC) United States $0.480B 0.00
REGENXBIO (RGNX) United States $0.475B 0.00
ACELYRIN, INC (SLRN) United States $0.472B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.466B 0.00
MeiraGTx Holdings (MGTX) United States $0.463B 0.00
Allogene Therapeutics (ALLO) United States $0.463B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.458B 0.00
Aura Biosciences (AURA) United States $0.447B 0.00
Alumis (ALMS) United States $0.447B 0.00
Foghorn Therapeutics (FHTX) United States $0.436B 0.00
Tango Therapeutics (TNGX) United States $0.421B 0.00
Prime Medicine (PRME) United States $0.420B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.413B 0.00
Sangamo Therapeutics (SGMO) United States $0.392B 0.00
Revance Therapeutics (RVNC) United States $0.391B 0.00
Alpha Teknova (TKNO) United States $0.391B 0.00
Alector (ALEC) United States $0.386B 0.00
Codexis (CDXS) United States $0.375B 0.00
MaxCyte (MXCT) United States $0.374B 0.00
Contineum Therapeutics (CTNM) United States $0.363B 0.00
XOMA Royalty (XOMA) United States $0.356B 0.00
Northwest Biotherapeutics (NWBO) United States $0.354B 0.00
EnGene Holdings (ENGN) Canada $0.340B 0.00
Kamada (KMDA) Israel $0.337B 20.96
AC Immune (ACIU) Switzerland $0.334B 0.00
Jasper Therapeutics (JSPR) United States $0.331B 0.00
Kodiak Sciences (KOD) United States $0.326B 0.00
Design Therapeutics (DSGN) United States $0.318B 0.00
Voyager Therapeutics (VYGR) United States $0.309B 7.96
ITeos Therapeutics (ITOS) United States $0.304B 0.00
Neurogene (NGNE) United States $0.302B 0.00
Nautilus Biotechnology (NAUT) United States $0.301B 0.00
C4 Therapeutics (CCCC) United States $0.300B 0.00
Q32 Bio (QTTB) United States $0.299B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.297B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.296B 0.00
Absci (ABSI) United States $0.294B 0.00
Eton Pharmaceuticals (ETON) United States $0.290B 0.00
Atea Pharmaceuticals (AVIR) United States $0.285B 0.00
Rezolute (RZLT) United States $0.285B 0.00
UniQure (QURE) Netherlands $0.282B 0.00
Prima BioMed (IMMP) Australia $0.280B 0.00
Urogen Pharma (URGN) United States $0.279B 0.00
Artiva Biotherapeutics (ARTV) United States $0.272B 0.00
Lifecore Biomedical (LFCR) United States $0.269B 0.00
Poseida Therapeutics (PSTX) United States $0.266B 0.00
Ocugen (OCGN) United States $0.264B 0.00
Precigen (PGEN) United States $0.264B 0.00
Fate Therapeutics (FATE) United States $0.261B 0.00
Abeona Therapeutics (ABEO) United States $0.260B 0.00
Semper Paratus Acquisition (TVGN) United States $0.256B 0.00
ATyr Pharma (ATYR) United States $0.254B 0.00
Mersana Therapeutics (MRSN) United States $0.252B 0.00
Anika Therapeutics (ANIK) United States $0.249B 0.00
Benitec Biopharma (BNTC) United States $0.244B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.240B 0.00
Biomea Fusion (BMEA) United States $0.233B 0.00
BioStem Technologies (BSEM) $0.231B 20.47
Zentalis Pharmaceuticals (ZNTL) United States $0.230B 0.00
TScan Therapeutics (TCRX) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.225B 0.00
Trevi Therapeutics (TRVI) United States $0.224B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.219B 0.00
Solid Biosciences (SLDB) United States $0.216B 0.00
Molecular Partners AG (MOLN) Switzerland $0.213B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.213B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
XBiotech (XBIT) United States $0.208B 0.00
Sutro Biopharma (STRO) United States $0.207B 0.00
Climb Bio (CLYM) United States $0.205B 0.00
Compass Therapeutics (CMPX) United States $0.205B 0.00
Inhibrx Biosciences (INBX) United States $0.204B 0.00
Editas Medicine (EDIT) United States $0.201B 0.00
DiaMedica Therapeutics (DMAC) United States $0.201B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.192B 0.00
Kyverna Therapeutics (KYTX) United States $0.190B 0.00
Tenaya Therapeutics (TNYA) United States $0.189B 0.00
2seventy Bio (TSVT) United States $0.186B 0.00
Opthea (OPT) Australia $0.185B 0.00
Checkpoint Therapeutics (CKPT) United States $0.183B 0.00
Caribou Biosciences (CRBU) United States $0.183B 0.00
Inozyme Pharma (INZY) United States $0.181B 0.00
Zura Bio (ZURA) United States $0.178B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Verastem (VSTM) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Fulcrum Therapeutics (FULC) United States $0.175B 0.00
Nkarta (NKTX) United States $0.173B 0.00
Instil Bio (TIL) United States $0.171B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.169B 0.00
ScPharmaceuticals (SCPH) United States $0.168B 0.00
Candel Therapeutics (CADL) United States $0.164B 0.00
TuHURA Biosciences (HURA) United States $0.159B 0.00
Gossamer Bio (GOSS) United States $0.158B 0.00
Bright Minds Biosciences (DRUG) United States $0.157B 0.00
Puma Biotechnology (PBYI) United States $0.147B 6.25
Sagimet Biosciences (SGMT) United States $0.146B 0.00
Adherex Technologies (FENC) United States $0.146B 0.00
Cidara Therapeutics (CDTX) United States $0.144B 0.00
PepGen (PEPG) United States $0.144B 0.00
Black Diamond Therapeutics (BDTX) United States $0.144B 0.00
Seer (SEER) United States $0.143B 0.00
Elutia (ELUT) United States $0.142B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.142B 0.00
Inventiva S.A (IVA) France $0.137B 0.00
Innate Pharma S.A (IPHA) France $0.132B 0.00
Seres Therapeutics (MCRB) United States $0.131B 0.00
Ventyx Biosciences (VTYX) United States $0.131B 0.00
Vigil Neuroscience (VIGL) United States $0.130B 0.00
Compugen (CGEN) Israel $0.126B 70.50
Adverum Biotechnologies (ADVM) United States $0.126B 0.00
Coherus BioSciences (CHRS) United States $0.126B 0.00
Cardiff Oncology (CRDF) United States $0.125B 0.00
Skye Bioscience (SKYE) United States $0.125B 0.00
InflaRx (IFRX) Germany $0.122B 0.00
Repare Therapeutics (RPTX) Canada $0.119B 0.00
Rani Therapeutics Holdings (RANI) United States $0.119B 0.00
Oncobiologics (OTLK) United States $0.119B 0.00
TELA Bio (TELA) United States $0.119B 0.00
Alto Neuroscience (ANRO) United States $0.116B 0.00
CAMP4 Therapeutics (CAMP) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
INmune Bio (INMB) United States $0.108B 0.00
Inovio Pharmaceuticals (INO) United States $0.106B 0.00
Monopar Therapeutics (MNPR) United States $0.106B 0.00
Akoya Biosciences (AKYA) United States $0.105B 0.00
MediciNova (MNOV) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.104B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.100B 0.00
Scilex Holding (SCLX) United States $0.100B 0.00
Immunic (IMUX) United States $0.099B 0.00
Nuvectis Pharma (NVCT) United States $0.099B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.098B 0.00
Leap Therapeutics (LPTX) United States $0.098B 0.00
Adagene (ADAG) China $0.097B 0.00
Adlai Nortye (ANL) Cayman Islands $0.097B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.095B 0.00
Invizyne Technologies (IZTC) $0.093B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Annovis Bio (ANVS) United States $0.092B 0.00
Generation Bio (GBIO) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
FibroBiologics (FBLG) United States $0.090B 0.00
Genelux (GNLX) United States $0.088B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Genenta Science S.p.A (GNTA) Italy $0.086B 0.00
Werewolf Therapeutics (HOWL) United States $0.085B 0.00
Invivyd (IVVD) United States $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
Renovaro (RENB) United States $0.082B 0.00
Galena Biopharma (SLS) United States $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.082B 0.00
23andMe Holding (ME) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Agenus (AGEN) United States $0.078B 0.00
Allakos (ALLK) United States $0.078B 0.00
PDS Biotechnology (PDSB) United States $0.078B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
I-Mab (IMAB) China $0.077B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.076B 0.00
BioAtla (BCAB) United States $0.076B 0.00
Ovid Therapeutics (OVID) United States $0.075B 0.00
ALX Oncology Holdings (ALXO) United States $0.074B 0.00
Adicet Bio (ACET) United States $0.074B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.074B 0.00
Aligos Therapeutics (ALGS) United States $0.072B 0.00
VistaGen Therapeutics (VTGN) United States $0.072B 0.00
CytomX Therapeutics (CTMX) United States $0.070B 5.24
Bluebird Bio (BLUE) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
Atara Biotherapeutics (ATRA) United States $0.066B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Spero Therapeutics (SPRO) United States $0.063B 16.57
Celularity (CELU) United States $0.061B 0.00
CervoMed (CRVO) United States $0.059B 0.00
X4 Pharmaceuticals (XFOR) United States $0.058B 0.00
Dyadic (DYAI) United States $0.057B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
Aadi Bioscience (AADI) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Connect Biopharma Holdings (CNTB) United States $0.055B 0.00
Theratechnologies (THTX) Canada $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Earth Science Tech (ETST) United States $0.054B 0.00
Vor Biopharma (VOR) $0.054B 0.00
Aileron Therapeutics (ALRN) United States $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.053B 0.00
Boundless Bio (BOLD) United States $0.052B 0.00
OnKure Therapeutics (OKUR) United States $0.052B 0.00
Enzo Biochem (ENZ) United States $0.051B 0.00
BGM Group (BGM) China $0.051B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.050B 0.00
Immix Biopharma (IMMX) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.047B 0.00
IO Biotech (IOBT) Denmark $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
DBV Technologies S.A (DBVT) France $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.044B 0.00
Omega Therapeutics (OMGA) United States $0.044B 0.00
Rallybio (RLYB) United States $0.042B 0.00
Affimed (AFMD) Germany $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.040B 0.00
AN2 Therapeutics (ANTX) United States $0.040B 0.00
Exicure (XCUR) United States $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
Beyond Air (XAIR) United States $0.039B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.038B 0.00
Rapt Therapeutics (RAPT) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Intensity Therapeutics (INTS) United States $0.036B 0.00
Elevation Oncology (ELEV) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Curis (CRIS) United States $0.034B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
NextCure (NXTC) United States $0.033B 0.00
Grace Therapeutics (GRCE) Canada $0.033B 0.00
Lantern Pharma (LTRN) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Opus Genetics (IRD) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Passage Bio (PASG) United States $0.031B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
HCW Biologics (HCWB) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
Longeveron (LGVN) United States $0.028B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
BRIACELL THERAP (BCTX) Canada $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Abpro Holdings (ABP) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
LakeShore Biopharma (LSB) China $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
IN8bio (INAB) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Gelteq (GELS) $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Cingulate (CING) United States $0.015B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
NKGen Biotech (NKGN) United States $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Quantum Biopharma (QNTM) Canada $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Eyenovia (EYEN) United States $0.009B 0.00
Onconetix (ONCO) United States $0.009B 0.00
Evaxion Biotech (EVAX) Denmark $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Vincerx Pharma (VINC) United States $0.008B 0.00
Ensysce Biosciences (ENSC) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Syros Pharmaceuticals (SYRS) United States $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Biora Therapeutics (BIOR) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Aptevo Therapeutics (APVO) United States $0.006B 0.00
Allarity Therapeutics (ALLR) United States $0.006B 0.00
Carmell (CTCX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Polyrizon (PLRZ) $0.004B 0.00
Cyclerion Therapeutics (CYCN) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Aptose Biosciences (APTO) Canada $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Eterna Therapeutics (ERNA) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00